INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845paa6 Class: NOTE 3.250% 7/0

PALISADE CAPITAL MANAGEMENT, LP's Holding History (CIK: 0001009006)

Note: Option positions (PUT/CALL) are excluded.

Q4 2018
Shares 975,000 Value ($000) $900 Avg Close — Range —
Q3 2018
Shares 975,000 Value ($000) $985 Avg Close — Range —
Q2 2018
Shares 1,476,000 Value ($000) $1,297 Avg Close — Range —
Q1 2018
Shares 1,476,000 Value ($000) $1,192 Avg Close — Range —
Q4 2017
Shares 1,476,000 Value ($000) $1,183 Avg Close — Range —
Q3 2017
Shares 1,476,000 Value ($000) $1,155 Avg Close — Range —
Q2 2017
Shares 1,476,000 Value ($000) $1,439 Avg Close — Range —
Q1 2017
Shares 1,476,000 Value ($000) $1,385 Avg Close — Range —
Q4 2016
Shares 1,476,000 Value ($000) $1,326 Avg Close — Range —
Q3 2016
Shares 1,479,000 Value ($000) $1,656 Avg Close — Range —